1999
DOI: 10.1016/s0002-9610(99)00070-7
|View full text |Cite
|
Sign up to set email alerts
|

Benefits and safety of hepatic resection for colorectal metastases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
53
3
2

Year Published

2001
2001
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(58 citation statements)
references
References 6 publications
0
53
3
2
Order By: Relevance
“…The reason for the different survival times between both groups may be due to the aggressiveness of original carcinoma cells. Although there is no report comparing the prognosis of metastases from stomach and colon carcinoma, several reports have shown that patients with advanced and recurrent colon carcinoma had a better prognosis than those with gastric carcinoma [16, 17, 18, 19, 20]. The prognosis of secondary ovarian carcinomas with respect to the primary tumor site, has not been reported previously, and our data suggest that the primary site might be an important prognostic factor.…”
Section: Discussioncontrasting
confidence: 51%
“…The reason for the different survival times between both groups may be due to the aggressiveness of original carcinoma cells. Although there is no report comparing the prognosis of metastases from stomach and colon carcinoma, several reports have shown that patients with advanced and recurrent colon carcinoma had a better prognosis than those with gastric carcinoma [16, 17, 18, 19, 20]. The prognosis of secondary ovarian carcinomas with respect to the primary tumor site, has not been reported previously, and our data suggest that the primary site might be an important prognostic factor.…”
Section: Discussioncontrasting
confidence: 51%
“…Detecting recurrent disease is only useful if early treatment leads to an improved prognosis. Although the majority of relapsing patients are incurable, around one third of patients with isolated distant or locoregional recurrence are alive at 5 years after treatment, and long-term survival is possible [21,[23][24][25][26][27][28][29][30][31][32][33] . Rates of resection for isolated or limited disease recurrence have increased, and approximately 20% of patients with hepatic relapse are currently considered for surgery [24,32,34] .…”
Section: Introductionmentioning
confidence: 99%
“…Surgical resection of liver and lung metastases may be more effective than resection of recurrences at other sites. The reported 5-year survival rate following resection of liver or lung metastases ranges from 30 to 50% [1,2,3,4,5,6,7]. …”
Section: Discussionmentioning
confidence: 99%
“…Many reports have suggested that resection of metastatic recurrences may provide survival benefits for patients who have undergone curative resection of colorectal cancer [1,2,3,4,5,6,7]. Hepatic and pulmonary metastases are known to be common and provide good indications for metastasectomy, as do brain, spinal, and peritoneal metastases.…”
Section: Introductionmentioning
confidence: 99%